IP Library Granted Patent US 11,198,001
Granted Patent B1
US 11,198,001 · App. 15/887,929 · Granted Dec 14, 2021

Systems and methods for automatically programming patient therapy devices

Inventors: James R. Thacker (Homer, CA); Jon Parker (San Jose, CA)
Assignee: Nevro Corp.
A61N1/36071A61N1/36171
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,198,001
App. No.
15/887,929
Granted
Dec 14, 2021
Kind
B1
Abstract

Methods for automatically programming a signal generator in a patient therapy system and associated systems are disclosed. A representative method comprises retrieving data including therapy program parameters, level of efficacy, and medication use corresponding to a plurality of time periods; identifying from the data a target time period having a corresponding level of efficacy; determining from the data if medication was used during the target time period; determining from the data if medication was used during a prior time period immediately before the target time period; calculating a lead position confidence factor; and programming the signal generator to repeat therapy with the therapy program parameters corresponding to the target time period if the confidence factor is greater than a threshold value and medication was used during the prior time period and not during the target time period.

Claims (30)

1. A method for programming a signal generator in a patient therapy system, the method comprising:

applying a therapy signal to a patient according to a first program;

receiving information from the patient regarding a level of efficacy for the first program;

receiving information regarding lead location;

assigning a confidence factor to the lead location;

automatically selecting a second program based on the level of efficacy, and lead location when the confidence factor exceeds a threshold value; and

applying a therapy signal to the patient according to the second program.

2. The method of claim 1 , wherein the patient therapy system is a spinal cord stimulation system.

3. The method of claim 2 , wherein the level of efficacy corresponds to a level of pain relief.

4. The method of claim 1 , wherein information regarding lead location is derived from an x-ray of the patient.

5. The method of claim 1 , further comprising retrieving information from the signal generator regarding the first program and selecting the second program based on the information from the signal generator regarding the first program.

6. The method of claim 1 , wherein the first and second programs each include a stimulation duration and a stimulation amplitude.

7. The method of claim 1 , further comprising receiving information corresponding to the patient's medication use and selecting the second program based at least in part on the information corresponding to the patient's medication use.

8. The method of claim 1 , wherein the first program includes a first electrode configuration and the second program includes a second electrode configuration different than the first electrode configuration.

9. A method for programming a signal generator in a patient therapy system, the method comprising:

directing the signal generator to apply a first therapy signal to a patient via a signal delivery device according to a first program;

receiving information from the patient regarding a level of efficacy for the first program;

recording the information from the patient in a memory unit housed in the signal generator;

retrieving the level of efficacy for the first program from the memory unit;

receiving information corresponding to a location of the signal delivery device;

assigning a confidence factor to the lead location;

automatically selecting a second program based on the level of efficacy, and the signal delivery device location when the confidence factor exceeds a threshold value; and

directing the signal generator to apply a second therapy signal to the patient via the signal delivery device according to the second program.

10. The method of claim 9 , wherein the patient therapy system is a spinal cord stimulation system.

11. The method of claim 9 , wherein the level of efficacy corresponds to a level of pain relief.

12. The method of claim 9 , wherein information regarding lead location is derived from an x-ray of the patient.

13. The method of claim 9 , further comprising retrieving information from the signal generator regarding the first program and selecting the second program based on the information from the signal generator regarding the first program.

14. The method of claim 9 , wherein the first and second programs each include a stimulation duration and a stimulation amplitude.

15. The method of claim 9 , further comprising receiving information corresponding to the patient's medication use and selecting the second program based at least in part on the information corresponding to the patient's medication use.

16. The method of claim 9 , wherein the first program includes a first electrode configuration and the second program includes a second electrode configuration different than the first electrode configuration.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2018
From: THACKER, JAMES R.; PARKER, JON
To: NEVRO CORP.
Reel/Frame 047327/0705 →
Continuity (3)
Division 15017512 · Feb 5, 2016
Division 14161554 · Jan 22, 2014
Provisional Application 61755393 · Jan 22, 2013
Cited By (1)
US 12,329,971